Dexmedetomedine Infusion Versus Fentanyl Infusion for Donor Anlgesia During Living Donor Hepatectomy

To compare between the analgesic effect of dexmedetomedine infusion versus Fentanyl infusion during donor hepatectomy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Donor Hepatectomy

Age range

20 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mansoura university

Al Mansurah, Dkahleya, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

donors of living donor liver transplantation

Exclusion criteria

patient refusal Known allergy to dexmedetomedine

Treatment and study plan

dexmedetomedine

Drug

intraoperative infusion

Fentanyl

Drug

Primary outcomes

postoperative VAS scale

Time frame: 3 days

Sponsors and collaborators

Lead sponsor

Mansoura University

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Aug 24, 2015
Registry last updated: Aug 24, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed